This is the official journal for mechanistic pathophysiology and translational therapeutic research, and a leading journal advancing the mechanistic understanding of disease and translating molecular and cellular insights into therapeutic innovation and precision medicine.

 

Nexus of Pathophysiology and Therapeutics (NPT) is a premier, peer-reviewed, international open-access journal dedicated to advancing the mechanistic understanding of disease biology and translating these profound insights into therapeutic innovations and precision medicine.

Our Mission: To bridge the critical gap between fundamental laboratory discovery and clinical therapeutic application. We achieve this by publishing high-quality, rigorous research that elucidates disease mechanisms, informs targeted therapeutic development, and enhances translational and real-world clinical impact.


Key Journal Features

  • Rigorous Peer Review: A strict double-blind peer-review process conducted by independent global experts ensures scientific integrity, profound mechanistic depth, and translational validity.

  • Expert Editorial Oversight: Dedicated Section Editors closely manage the evaluation pipeline, reviewer selection, and quality control under the direct leadership of the Editor-in-Chief.

  • Continuous Publication Model: To foster rapid scientific dissemination, accepted articles are finalized, typeset, and published online immediately, ensuring no artificial publication delays.

  • Fully Open Access: Published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, all content is immediately and permanently accessible to the global scientific community for free, allowing unrestricted use and distribution with proper attribution.


The Submission & Review Workflow

1. Initial Editorial Screening

Every manuscript undergoes a swift, comprehensive preliminary assessment by the Editorial Board. Submissions are screened for:

  • Tight alignment with the journal’s explicit aims and scope.

  • Scientific originality and methodological rigor.

  • Strong mechanistic relevance (either derived directly from empirical data or thoroughly evaluated within a robust biological framework in the Introduction and Discussion sections).

2. Peer Review & Timeline

Manuscripts that successfully pass the initial editorial screening are immediately routed to independent, expert peer review.

  • Review Format: Double-blind (authors and reviewers remain entirely anonymous).

  • First Decision Timeline: The first editorial decision is typically communicated to authors within 5 to 6 weeks from the date of submission.


Join Our Global Community

NPT proudly welcomes high-quality contributions from biomedical researchers, translational scientists, and clinicians worldwide. We prioritize work that deepens the understanding of disease processes, identifies and characterizes novel therapeutic targets, or explores complex pharmacological pathways—particularly when integrating experimental, computational, and clinical methodologies.

Submit your manuscript today and join a world-class platform where mechanistic discoveries drive the future of therapeutic innovation.

 

Submit Manuscript | Guide for Authors | Aims and Scope

Publication Information
Indexing and Abstracting